Portola Says Stock Drop Was 'Reversal Of Fortune,' Not Fraud
Portola Pharmaceuticals pushed a California federal judge to toss a proposed class action accusing the company of misstating the actual market value of its blood coagulant, Andexxa, arguing there is no...To view the full article, register now.
Already a subscriber? Click here to view full article